Prenetics Global Ltd (PRE) stock
PRENasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as PRENW
$16.72−0.92 (-5.22%)
Close on Nov 12, 2026Market cap $282.14MP/E –Yield –
Prenetics Global r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $5.13M, down 43.3% from the year before. The highest annual figure on record is $9.17M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.13M | -43.3% |
| FY2024 | Dec 31, 2024 | $9.05M | -1.3% |
| FY2023 | Dec 31, 2023 | $9.17M | +53.1% |
| FY2022 | Dec 31, 2022 | $5.99M | -6.3% |
| FY2021 | Dec 31, 2021 | $6.39M | +129.7% |
| FY2020 | Dec 31, 2020 | $2.78M | – |
See a number that looks wrong?